Objective: To investigate the corresponding cytological diagnoses, Gene Expression Classifier (GEC) results and ultrasound features of thyroid nodules diagnosed as non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP), as well as any coexisting pathology.
ies to date have evaluated their performance. 10, 11 The primary objective of our current study was to examine our institutional experience with pre-operative assessment of histologically confirmed cases of NIFTP, specifically the distribution of corresponding cytological diagnoses and GEC results. A secondary aim was to review the ultrasound features of NIFTP nodules as reported during the initial examination.
| MATERIALS AND METHODS
A retrospective review of the electronic pathology database at the Hospital of the University of Pennsylvania was performed. All thyroid nodules histologically diagnosed as NIFTP were identified over a FNAs were performed under ultrasound guidance by radiologists or endocrinologists using a 25 or 27-gauge needle attached to a 10-mL syringe without suction. Air-dried direct smears were stained with Diff-Quik â for rapid on-site evaluation. PTCs, particularly when the atypia is subtle or focal, they are frequently assigned an indeterminate cytological diagnosis within the TBSRTC classification system 7, 10, 12, [18] [19] [20] [21] [22] [23] [24] (Table 3) . In our study, of the 72 cases of NIFTP with a prior cytological diagnosis, 40.3%
were classified as AUS/FLUS and 37.5% as FN/SFN/FNOF. This is in contrast to classic type PTCs, which are more likely to be stratified as malignant given their more pronounced cytological and architectural atypia. 22 See Figure 1 for an example of a NIFTP nodule as seen on ultrasound, FNA and surgical pathology. Thus, FNA continues to be of limited utility in discriminating between the various follicular-patterned lesions due to similar and/or overlapping cytological features and the inability to discern capsular or vascular invasion. 25 In our study, concurrent GEC results were available for 32 (37%)
cases with the majority of NIFTP nodules (81.3%) classified as suspicious. Only few studies have investigated the GEC results of NIFTPs, but our findings mirrored previously reported results. In a study by Jiang et al, 10 four NIFTPs underwent GEC analysis, all of which were classified as suspicious with AUS/FLUS cytology. Wong et al 11 reviewed 63 indeterminate nodules with a suspicious GEC result. Of these, 61 were excised and 14 were histologically compatible with non-invasive follicular variant PTC, although due to the design of the study, it is unknown how many cases would have been classified as benign by GEC. Additionally, a study by Hang et al 26 showed that most NIFTP cases were classified as suspicious with AUS (n = 19) or SFN (n = 4) cytology; the two remaining cases of NIFTP were called AUS but yielded no GEC result due to insufficient RNA material.
These early studies suggest that the reclassification of NIFTPs from a malignant to a benign entity decreases the positive predictive value of malignancy in the GEC test. Thus, in the face of a suspicious GEC result, careful consideration should be given to all preoperative characteristics of a thyroid nodule, including nodule size, sonographic features, cytology and the presence of other pathological nodules, in determining the surgical course of action. Furthermore, given that GEC was originally validated before the change in nomenclature occurred, the test performance characteristics will need to be re-evaluated with larger case cohorts to place these new findings into their appropriate context.
We also retrospectively reviewed the sonographic features of NIFTP nodules in our cohort ( F I G U R E 1 A case of non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Pre-operative ultrasound showed a hypoechoic thyroid nodule (A). The FNA specimen, diagnosed as atypia of unknown significance/follicular lesion of undetermined significance, primarily showed cytomorphological features of a hyperplastic thyroid nodule with rare groups of cells with atypical nuclei characterised by nuclear elongation, chromatin clearing and intranuclear grooves (arrow; B, alcohol-fixed smear preparation, Papanicolaou stain, 1009). Gene expression classifier testing was reported as suspicious and a total thyroidectomy was performed, which showed a non-invasive thinly encapsulated follicular-patterned nodule (C, haematoxylin and eosin stain, 109). The cells lining the follicles demonstrated nuclear features of papillary thyroid carcinoma (D, haematoxylin and eosin stain, 609) with a hypoechoic rim, hypervascular and hypoechoic for a microfollicular nodule, or isoechoic for a macrofollicular nodule. In comparison, discriminating parameters for overtly invasive encapsulated follicular variant PTCs included hypoechogenicity with irregular or lobulated margins, while for infiltrative follicular variant PTCs, avascularity and hypoechogenicity with blurred margins were more common features. 27 Finally, the histological landscape of thyroid resection specimens was reviewed (Table 2) . While NIFTPs frequently occurred in a background of malignant neoplasms (46.3% of cases), most of these were incidental sub-centimetre papillary thyroid microcarcinomas (85.3%).
Unless signs of clinical progression are noted, such as lymph node metastases, sonographic evidence of extrathyroidal extension, proximity of the nodule to the recurrent laryngeal nerve or trachea, active surveillance may be an adequate therapeutic approach to papillary thyroid microcarcinomas, which are clinically considered to be a very low risk cancer with >90% disease-free survival and a mortality rate of up to 0.3%. 31, 32 Additionally, in our study lymph node metastases were present in only two cases; one case had a PTC with tall cell features and both cases had multifocal microcarcinomas.
Although examination of the negative histological features associated with PTCs was beyond the scope of our study, Wong et al 33 noted that in reclassifying NIFTPs as benign neoplasms, the rates of unfavourable parameters such as extrathyroidal extension, lymphovascular invasion and lymph node metastases increased in the other subtypes of PTCs. More studies with long-term follow-up will be needed to fully characterise the prognostic implications of this diagnostic paradigm shift on other PTCs.
| CONCLUSION
The recently introduced NIFTP terminology reflects the indolent nature of these tumours, which accordingly warrant conservative therapy. While management will need to be individualised for each patient and ultimately depends on the histological findings in the resection specimen, given that the majority of NIFTPs have indeterminate cytology on FNA and a GEC result of suspicious, these findings together can suggest initial conservative therapy.
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